Sundar Padmavathi 4
4 · OncoCyte Corp · Filed Dec 15, 2020
Insider Transaction Report
Form 4
Sundar Padma
SVP, Marketing & Market Access
Transactions
- Award
Common Stock
2020-12-11+4,177→ 4,177 total
Footnotes (1)
- [F1]The shares of the Issuer's common stock were issued to the Reporting Person for the repayment of deferred compensation in lieu of cash at a price of $2.07 per share.